Biolase PE Ratio 2010-2024 | BIOL

Current and historical p/e ratio for Biolase (BIOL) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Biolase PE ratio as of May 22, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Biolase PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-05-22 0.19 0.00
2024-03-31 0.19 $-14.58 0.00
2023-12-31 1.12 $-32.58 0.00
2023-09-30 1.86 $-158.82 0.00
2023-06-30 7.07 $-264.93 0.00
2023-03-31 28.12 $-347.00 0.00
2022-12-31 65.00 $-410.00 0.00
2022-09-30 243.00 $-357.00 0.00
2022-06-30 458.00 $-297.00 0.00
2022-03-31 883.00 $-206.00 0.00
2021-12-31 975.00 $-275.00 0.00
2021-09-30 1598.25 $-375.00 0.00
2021-06-30 1745.25 $-850.00 0.00
2021-03-31 2107.25 $-1,150.00 0.00
2020-12-31 1041.75 $-1,475.00 0.00
2020-09-30 687.75 $-1,625.00 0.00
2020-06-30 1157.50 $-1,725.00 0.00
2020-03-31 937.50 $-1,875.00 0.00
2019-12-31 1381.75 $-1,975.00 0.00
2019-09-30 2350.00 $-2,475.00 0.00
2019-06-30 3675.00 $-2,425.00 0.00
2019-03-31 5950.00 $-2,575.00 0.00
2018-12-31 2475.00 $-2,625.00 0.00
2018-09-30 5175.00 $-2,425.00 0.00
2018-06-30 3025.00 $-2,600.00 0.00
2018-03-31 5075.00 $-3,500.00 0.00
2017-12-31 5330.00 $-3,625.00 0.00
2017-09-30 7535.00 $-3,875.00 0.00
2017-06-30 12125.00 $-4,000.00 0.00
2017-03-31 16875.00 $-3,250.00 0.00
2016-12-31 17500.00 $-3,375.00 0.00
2016-09-30 21875.00 $-3,125.00 0.00
2016-06-30 14625.00 $-3,375.00 0.00
2016-03-31 16375.00 $-4,125.00 0.00
2015-12-31 10513.75 $-4,375.00 0.00
2015-09-30 11250.00 $-4,750.00 0.00
2015-06-30 21750.00 $-4,625.00 0.00
2015-03-31 25250.00 $-5,250.00 0.00
2014-12-31 32875.00 $-5,750.00 0.00
2014-09-30 31125.00 $-5,496.27 0.00
2014-06-30 27500.00 $-6,105.14 0.00
2014-03-31 30125.00 $-4,965.29 0.00
2013-12-31 35199.01 $-4,320.54 0.00
2013-09-30 23662.78 $-3,208.50 0.00
2013-06-30 44085.42 $-1,842.26 0.00
2013-03-31 48767.33 $-1,581.38 0.00
2012-12-31 22555.46 $-1,201.69 0.00
2012-09-30 20623.52 $-2,284.53 0.00
2012-06-30 23538.70 $-2,396.89 0.00
2012-03-31 32550.01 $-2,024.10 0.00
2011-12-31 30714.89 $-1,771.54 0.00
2011-09-30 35498.97 $-938.46 0.00
2011-06-30 60219.38 $-1,846.82 0.00
2011-03-31 56491.19 $-3,447.79 0.00
2010-12-31 20098.72 $-5,626.49 0.00
2010-09-30 13437.43 $-6,431.58 0.00
2010-06-30 17342.33 $-4,708.84 0.00
2010-03-31 22395.72 $-1,607.90 0.00
2009-12-31 21936.32 $-1,263.35 0.00
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.006B $0.049B
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $72.451B 20.33
Becton Dickinson (BDX) United States $67.758B 19.17
West Pharmaceutical Services (WST) United States $24.351B 43.64
Cardinal Health (CAH) United States $23.460B 13.41
Align Technology (ALGN) United States $19.658B 37.95
Cooper (COO) United States $19.200B 29.05
Labcorp (LH) United States $16.960B 14.60
Henry Schein (HSIC) United States $9.268B 16.49
DENTSPLY SIRONA (XRAY) United States $5.824B 15.08
Merit Medical Systems (MMSI) United States $4.773B 26.16
CONMED (CNMD) United States $2.309B 20.94
Patterson (PDCO) United States $2.193B 10.51
STAAR Surgical (STAA) United States $2.091B 80.28
Atrion (ATRI) United States $0.831B 44.36
Lifevantage (LFVN) United States $0.095B 12.25
Pro-Dex (PDEX) United States $0.067B 33.88